Where Global Innovation
and Capital Meet
Sectors Consumer University Energy Financial Healthcare Industrial IT Media Services Telecoms Transport The Art of CVC Startups

Page 130

NexImmune collects IPO proceeds

NexImmune priced shares at $17 to raise $110m in an upsized offering, enabling Amgen and Pfizer to exit the Johns Hopkins University spinout.

Feb 15, 2021

Ensoma emerges with $70m series A

Takeda Ventures and Alexandria Venture Investments have taken part in a $70m series A round for Ensoma, with Takeda separately signing a strategic collaboration deal.

Feb 15, 2021

Immunai initiates $60m series A

Dexcel Pharma has co-led a $60m series A round for Immunai, which previously collected $20m in seed financing less than a year ago.

Feb 15, 2021

Seraxis secures $40m in series C

Eli Lilly has led a series C round for the diabetes treatment developer, which plans to complete preclinical testing of its lead therapy.

Feb 15, 2021

Pension fund commits to Lilly Asia Ventures

San Francisco Employees’ Retirement System commits $48m.

Feb 14, 2021

Illumina selects nine for accelerators

Illumina has also gathered £20m ($25m) to every graduate from its UK-based accelerator.

Feb 14, 2021

Delta Dental of Colorado adds venture fund

Ensemble Innovation Ventures Fund (EIVF) will target the health and wellness space.

Feb 14, 2021

DexCom monitors new ventures unit

Dexcom Ventures will invest in glucose sensing technology and adjacent areas.

Feb 14, 2021

SR One expands venture team

Chris Chai and Peter Van Vlasselaer, both former executives at SR One portfolio companies, have been hired by the GSK-backed VC firm as venture partners.

Feb 12, 2021

Hyperfine finds $90m in series D round

Alphabet's GV unit and Huami both took part as the portable MRI device developer completed an oversubscribed series D round.

Feb 12, 2021

© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here